neurooncology

neu·ro·on·col·o·gy

(nū'rō-on-kol'ŏ-jē),
The branch of medicine concerned with the direct and indirect effects of neoplasms on the nervous system, neuromuscular junction, and muscle.
[neuro- + onco- + G. logos, study]

neu·ro·on·col·o·gy

(nūr'ō-on-kol'ŏ-jē)
The branch of medicine concerned with the direct and indirect effects of neoplasms on the nervous system, neuromuscular junction, and muscle.
[neuro- + onco- + G. logos, study]
Mentioned in ?
References in periodicals archive ?
Nowadays, molecular markers have become an integral part of tumours assessment in modern neurooncology.
Recent applications of immunoperoxidase histochemistry in human neurooncology.
Senckenberg Institute of Neurooncology, will take part in the discussion.
Findings of the research are published online in the journal NeuroOncology.
Frame-Based Localization," Journal of NeuroOncology, vol.
Preclinical evaluation of ex vivo expanded/activated yS T cells for immunotherapy of glioblastoma multiforme," Journal of NeuroOncology, vol.
Wenxue Zhang is supported by the Chinese Society of NeuroOncology, Neuro-Oncology Research Project CSNO-2013MSD003, and Lingling Li is supported by the NSFC under
This neurology textbook contains 153 chapters by neurologists and other specialists mainly from the US, who cover the approach to the patient, diagnostic tests, cerebrovascular diseases, neurotrauma, dementia, headache and pain syndromes, epilepsy and paroxysmal disorders, central nervous system infections, demyelinating and inflammatory diseases, movement disorders, neuromuscular diseases, neurooncology, hydrocephalus and cerebral edema, spinal cord disorders, autonomic and sleep disturbances, systemic organ function and the brain, neurologic toxidromes, pediatric neurology, psychiatry and neurology, and recovery and end-of-life care.
7) The finding of mutations in IDH1 and IDH2 in diffuse gliomas has dramatically changed the practice of neuropathology and neurooncology.
The symposium also comprised parallel sessions on colorectal malignancies, genitourinary and gynaecological malignancies and neurooncology.
Prof Gumbleton has teamed up with Professor Geoff Pilkington from Portsmouth University, an internationally recognised and highly regarded scientist in the field of neurooncology.
Geoffrey Pilkington, Professor of Cellular and Molecular Neurooncology at the University of Portsmouth, who directs work funded by the charity Brain Tumour Research, says: "There are in excess of 120 different types of brain tumour and there are three major types.